You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

About Relvar Ellipta

Relvar Ellipta is an ICS/LABA combination for the treatment of asthma and COPD. 1 2 Relvar is the only ICS/LABA which delivers 24 hours of continuous efficacy from just one daily dose.

Find out more

Asthma Control Test

The ACT is a simple questionnaire that is quick to implement within a consultation and will provide an immediate overview of your patients symptoms in less than a minute.

Access the ACT

Relvar is available in the Ellipta.

Open, Inhale, Close – find out how to use Ellipta in three simple steps

Step-by-step guide to administering Relvar Ellipta

Before prescribing please consult the full SPC which you can request from GSK or access on the website of the Pharmaceutical Services of the Ministry of Health http://www.phs.moh.gov.cy/web/guest/drug-search
Prescription Only Medicine
Trade marks are owned by or licensed to the GSK group of companies.
© 2020 GSK group of companies or its licensor.
Retail price: RELVAR ELLIPTA 92MCG/22MCG PTP w.VAT 42,34 Euro HIO List PC2 9,28 Euro. RELVAR ELLIPTA 184MCG/22MCG PTP w.VAT 49,26 Euro HIO List PC2 9,91 Euro.

1. Relvar Ellipta 92/22 mcg. SmPC
2. Relvar Ellipta 184/22 mcg. SmPC